| [1] |
DU Lijuan, LIN Jianhua, YE Jinghuan, SONG Lu, PENG Yanfen, LIU Yuping.
Effect and mechanism of Yiqi tongfu xiere prescription on lipopolysaccharide-induced acute lung injury in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 599-607.
|
| [2] |
WANG Peipei, PAN Linkun, YANG Kui, FENG Dandan.
Qingluo Yin inhibits synovial angiogenesis induced by adjuvant in arthritis rats by regulating HIF-1α/VEGF pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 366-373.
|
| [3] |
CAO Jun, ZHOU Yanlin, AI Zhengwen, LI Shigang.
Research progress on mechanism of action of Chaenomeles speciosa Nakai in the treatment of rheumatoid arthritis bone restruction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 404-411.
|
| [4] |
DU Nan, WEI Miaoyan, XU Jin.
Advancements and frontiers in targeted therapy for pancreatic cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 183-192.
|
| [5] |
JIANG Haitao, XU Yangxian .
Research progress on the resistance mechanism of anti-angiogenesis targeted drugs in the treatment of colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 193-199.
|
| [6] |
WANG Liang, DENG Yinshuan, QU Tao, DA Chaoming, HE Yunfei, LIU Rui, NIU Weimin, YAN Weishun, CHEN Zhen, LI Shuo, YANG Zhiyun, GUO Binbin, LAI Xueqian.
The mechanism and application prospects of mitochondrial quality control in osteoarthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 282-288.
|
| [7] |
DUAN Yuxin, ZHANG Yanni, BAI Yi, YU Jinyao, SUN Jiayi, WANG Zejie, LI Ling, YE Qifa.
Progress of macrophage regulation mechanism in acute renal injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 110-117.
|
| [8] |
Celimuge, Hudeligen, XU Liang.
Network pharmacology-molecular docking analysis and experimental validation to explore the protective mechanism of Mongolian medicine Gaoyou on renal function
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 968-978.
|
| [9] |
JIN Baowei, WANG Kai, GUO Jianrong.
Research progress on the effects of propofol on tumor growth and metastasis mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 1042-1048.
|
| [10] |
ZHU Changmao, XIE Li, WU Zifeng, WANG Sen, ZHANG Qi, XU Xiangqing, YANG Chun.
Progress in the clinical application of the biased μ-opioid agonist oliceridine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 1057-1061.
|
| [11] |
LI Nana, LI Zijian.
Advances in the study of acquired FXIII deficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 1070-1075.
|
| [12] |
LIU Xuan, FENG Cuijuan, WANG Yiqiang, LI Fang.
Research progress of miRNA in ulcerative colitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 917-929.
|
| [13] |
WANG Dan, ZHANG Wenyan, LUO Renjie, CHEN Yuanjing, HAN Xue, QU Bo, FENG Shifang, NIE Xiazi, LIU Huiling.
Research progress of molecular docking in screening anti-cervical cancer drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 955-960.
|
| [14] |
ZHANG Li, LU Chang, AN Minghui, WANG Mengmeng, ZONG Xiaoyu, YU Lin, RAN Zhuo-ling, SONG Jing, LI Huijie, GONG Jian.
Mechanism of action and research progress of vaccine adjuvants
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(7): 785-791.
|
| [15] |
ZHANG Xiaowei, WANG Nan, DAI Mengge, LIU Ruijuan, MA Ting.
Research progress on material basis and mechanism of Hedyotis Diffusa-Scutellaria Barbata Herb Pair in the treatment of gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(7): 831-840.
|